Vera Therapeutics company info

What does Vera Therapeutics do?
Vera Therapeutics (NASDAQ:VERA) is a biotechnology company focused on advancing treatments for serious immunological diseases. Their operations are concentrated on developing and commercializing novel therapies aimed at improving the lives of patients battling conditions where current treatments fall short. A key project in their pipeline is the pursuit of innovative solutions for kidney diseases, with a strong emphasis on precision medicine to tailor treatments to individual patient needs. Vera Therapeutics is dedicated to pushing the boundaries of science to discover and develop therapies that can make a significant difference in patient care. Their objective is to lead with science-driven approaches, ensuring that their developments not only address unmet medical needs but also offer improved outcomes for patients worldwide.
Vera Therapeutics company media
Company Snapshot

Is Vera Therapeutics a public or private company?

key
Ownership
Public

How many people does Vera Therapeutics employ?

people
Employees
61

What sector is Vera Therapeutics in?

pie chart
Sector
Health Care

Where is the head office for Vera Therapeutics?

location pin
Head Office
California, United States

What year was Vera Therapeutics founded?

founded flag
Year Founded
2016
What does Vera Therapeutics specialise in?
/Kidney Disease /Phase 3 Atacicept /Autoimmune Disorders /Clinical Stage Biopharmaceutical /Medical Research /Drug Development

What are the products and/or services of Vera Therapeutics?

Overview of Vera Therapeutics offerings
Atacicept, a fusion protein aimed at treating IgA nephropathy by inhibiting APRIL and BLyS molecules implicated in B cell maturation.
MAU868, a monoclonal antibody for combating BK virus in kidney transplant patients.
Research in chronic autoimmune and inflammatory diseases, focusing on identifying novel treatments.
Collaborations with pharmaceutical companies to develop and commercialize innovative therapies.
Patient support programs designed to assist with access to treatments and managing chronic diseases.
Investment in advanced technologies for drug development and delivery systems.

Who is in the executive team of Vera Therapeutics?

Vera Therapeutics leadership team
  • Dr. Marshall W. Fordyce M.D.
    Dr. Marshall W. Fordyce M.D.
    Founder, President, CEO & Director
  • Mr. Sean P. Grant M.B.A.
    Mr. Sean P. Grant M.B.A.
    Chief Financial Officer
  • Mr. Joseph R. Young M.B.A.
    Mr. Joseph R. Young M.B.A.
    Senior VP of Finance & Chief Accounting Officer
  • Mr. Julien E. Capers J.D.
    Mr. Julien E. Capers J.D.
    VP & Head of Legal
  • Ms. Kelly  Rauber
    Ms. Kelly Rauber
    VP & Head of Human Resources
  • Mr. Tom  Doan
    Mr. Tom Doan
    Senior Vice President of Development Operations
  • Ms. Lauren  Frenz
    Ms. Lauren Frenz
    Chief Business Officer
  • Dr. Neeraj  Pakala M.B.A., Ph.D.
    Dr. Neeraj Pakala M.B.A., Ph.D.
    Senior VP and Head of Product Development & Manufacturing